Patent details
EP3735970 Title: CEBRANOPADOL FOR TREATING PAIN IN SUBJECTS WITH IMPAIRED HEPATIC AND/OR IMPAIRED RENAL FUNCTION
Basic Information
- Publication number:
- EP3735970
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP201784469
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- CEBRANOPADOL FOR TREATING PAIN IN SUBJECTS WITH IMPAIRED HEPATIC AND/OR IMPAIRED RENAL FUNCTION
- French Title of Invention:
- CÉBRANOPADOL POUR LE TRAITEMENT DE LA DOULEUR CHEZ DES SUJETS À FONCTION HÉPATIQUE ALTÉRÉE ET/OU FONCTION RÉNALE ALTÉRÉE
- German Title of Invention:
- CEBRANOPADOL ZUR BEHANDLUNG VON SCHMERZEN BEI PATIENTEN MIT VERMINDERTER LEBER- UND/ODER NIERENFUNKTION
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 05/09/2023
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 11/09/2023
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 09/08/2023
- Unitary Effect Registration Date:
- 11/09/2023
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 22/01/2016
- Grant date:
- 09/08/2023
- EP Publication Date:
- 11/11/2020
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 09/08/2023
- EP B1 Publication Date:
- 09/08/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 22/01/2036
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 02/08/2023
- Name:
- Park Therapeutics, Inc.
- Address:
- 2033 Route 130, Monmouth Junction, NJ 08852, United States (US)
Inventor
1
- Name:
- CHRISTOPH, Annette
- Address:
- Germany (DE)
2
- Name:
- OSSIG, Joachim
- Address:
- Germany (DE)
3
- Name:
- BOINPALLY, Ramesh
- Address:
- United States (US)
4
- Name:
- FUSSEN, René
- Address:
- Germany (DE)
5
- Name:
- KLEIDEITER, Elke
- Address:
- Germany (DE)
Priority
- Priority Number:
- 201562106845 P
- Priority Date:
- 23/01/2015
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/407; A61P 29/00; A61P 25/36; A61P 25/04;
Publication
European Patent Bulletin
1
- Issue number:
- 202332
- Publication date:
- 09/08/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202341
- Publication date:
- 11/10/2023
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202341
- Publication date:
- 11/10/2023
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|